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T he International Symposium on Auto phagy (ISA) is an important meeting with a long history devoted solely to the topic of autophagy. Yoshimori Ohsumi (Tokyo Institute of Technology, Japan), who identified a series of autophagyrelated genes (ATG genes) in yeast [1] , proposed and organized the first ISA in Okazaki, Japan, in 1997. Over the years, the ISA sym posia have witnessed the explosive growth of autophagy research in the following spe cific areas: molecular dissection of core ATG gene products; genetic studies of the role of ATGs in multiple species; and patho physiological aspects of autophagy in higher eukary otes, including neurodegeneration, cancer and inflammation. The ISA, together with the prestigious Gordon Research Conferences (2003-), Keystone Symposia (2007-) and EMBO Courses and Workshops (2009-), has always provided an inter national forum for rosters of excellent speak ers to present new discoveries that advance our global understanding of autophagy.
The sixth ISA was no exception. It took place between 28 October and 1 November 2012, in Okinawa, an island with a unique history and subtropical cli mate, surrounded by beautiful beaches and the Pacific Ocean. It was organized by Tamotsu Yoshimori (Osaka U., Japan) and was devoted to six topics: autophagy machinery, selective autophagy, regula tion of autophagy, autophagy and diseases, autophagosome formation, and emerging autophagy. Here, we focus on newly iden tified players that participate in autophago some biogenesis and fusion, selective autophagy, and tumorigenesis associated with autophagy suppression-topics that were discussed at this conference.
Autophagy is highly inducible-starvation and other stresses increase the number of autophagosomes. Autophagosomes are gen erated on or in close proximity to the endo plasmic reticulum. However, fundamental questions remain as to whether the endo plasmic reticulum membrane is the sole source for the autophagosome and whether it is involved directly in autophagosome formation. Studies suggest that additional membranes derived from the Golgi com plex, mitochondria, the plasma membrane and recycling endosomes also contribute to autophagosome formation [2] . Thus, it is probable that autophagosome formation involves multiple and complicated processes. Elucidation of the origin of autophagoso mal membranes, as well as the molecular mechanisms underlying autophagosome for mation, are two of the most intriguing issues in the autophagy field.
Yoshimori Ohsumi and Hayashi Yamamoto (Tokyo Institute of Technology, Japan) identified small cytoplasmic vesicles containing Atg9 (designated Atg9 vesi cles) and showed that only a few Atg9 vesicles are required for a single round of autophagosome formation. They further identified Atg27, Trs85 (a specific sub unit of the transport protein particle III) and Ypt1 (a Rab GTPase) as components of Atg9 vesi cles. Although Atg9containing structures were thought to be a source of the lipids required for autophagosome formation, their data suggest that only a small quan tity of the lipids is supplied through these vesicles. Rather, Atg9 vesicles might be important to transport the TRAPPIII complex and Ypt1 to the preautophagosomal struc ture and phagophore assembly site (PAS), allowing them to function in the process of autophagosome formation.
Sharon Tooze (Cancer Research UK) demonstrated that vesicular transport from recycling endosomes also contributes to autophagosome formation. Her group showed that Rab11 and Unc51like kinase 1 (ULK1)positive vesicles are derived from recycling endosomes-a process that is negatively regulated by a Rab GAP, TBC1D14-and are required for autophago some formation. Interestingly, Rab11 has been proposed to be a mammalian homo logue of Ypt32 regulated by Ypt1. Further studies should provide new insights into the function of TRAPPIII complex, Rab11 and Ypt1 in autophagosome formation.
No ATG is an island-the connection of autophagy with diverse pathways and functions Once autophagosome formation is complete, the autophagosome fuses with the lysosome and any late endosomes. The molecular mechanism(s) of the fusion event have not been fully characterized. It has been suggested that Vam3, Vam7, Ykt6, and Vti1 participate in autophagosomevacuole fusion in yeast, and VAMP7, VAMP8 and VTI1 in mammals. However, specific soluble Nethylmaleimidesensitive fusion (NSF) attachment protein receptor (SNARE) protein(s) on the autophagosomal membrane remain to be identified. Noboru Mizushima (U. Tokyo, Japan) and his colleagues identi fied syntaxin 17 (Stx17) as an autophago somal SNARE. They found that Stx17 localizes to the outer membrane of the com pleted autophagosome on autophagy induc tion, although the location from which Stx17 is derived is not clear. Stx17 interacts with both synaptosomalassociated protein 29 (SNAP29) and the endosomal and lyso somal SNARE, VAMP8, which mediates fusion between autophagosomes and lysosomes. The isolation membranes and phagophores do not have Stx17, preventing premature fusion with the lysosome. Further experi ments are needed to clarify how Stx17 local izes only to completed autophagosomes but not to the isolation membrane.
Besides the fundamental role of starvation induced autophagy-in other words, the supply of building blocks for new macromol ecule synthesis and for energy productionmounting evidence points to the importance of selective autophagy, which degrades aggregated proteins, unnecessary or dam aged mitochondria and invading bacteria through ubiquitin signalling [3] . Such selec tive autophagy occurs both constitutively and in response to cellular stresses to maintain cellular homeostasis.
Studies have described the molecular mechanism by which damaged mitochon dria are selectively targeted to autophagy (mitophagy), and these studies also suggest that defects in this process underlie familial Parkinson disease [4] . Specifically, when the mitochondrial membrane potential is dis sipated, the E3 ubiquitin ligase parkin trans locates from the cytosol to mitochondria and ubiquitinates multiple substrates, ultimately leading to the sequestration and degradation of mitochondria by autophagy. This pro cess depends on the serine/threonine kinase (PTENinduced putative kinase 1) PINK1, which is imported and degraded in healthy mitochondria, but targeted and accumulated on the surface of dysfunctional mitochondria. Keiji Tanaka (Tokyo Metropolitan Institute of Medical Science, Japan) and colleagues have demonstrated that PINK1 is autophosphoryl ated after membrane potential dissipation. Importantly, this posttranslational modifica tion, which is disrupted by most of the patho genic PINK1 mutations, is required for parkin recruitment to mitochondria. How autophos phorylation activates PINK1 to localize par kin on damaged mitochondria remains to be elucidated. Regarding the physiological relevance of the parkin-PINK1mediated pathway, Richard Youle (NIH, USA) reported that loss of parkin causes synthetic, stronger neurodegeneration phenotypes in a mouse model expressing proofreadingdefective mitochondrial DNA (mtDNA) polymerase (mtDNA mutator mouse). One scenario could be that mitochondria rapidly accu mulate mtDNA mutations in the absence of quality control through mitophagy.
When bacteria invade host cells through endocytosis and phagocytosis, a selective type of autophagy termed 'xeno phagy', engulfs the pathogens to restrict their growth [5] . Although neither the target proteins nor the E3 ubiquitin ligases have been identified, invading bacteria such as Salmonella enterica, Listeria monocytogenes and Shigella flexneri become positive for ubiquitin when they access the cytosol by rupturing the endosome and phagosome limiting membrane. For example, the ubiq uitin coat surrounding cytosolic Salmonella is bound by the autophagy receptors p62 and nuclear dot protein 52 (NDP52) that also interact with microtubuleassociated proteins 1A/1B light chain 3 (LC3). Ivan Dikic (Goethe U. Frankfurt, Germany) and colleagues have shown that the pro tein kinase TANKbinding kinase 1 (TBK1) phosphorylates opti neurin (OPTN)-a new autophagy receptor-at Ser 177, enhancing LC3binding and autophagic degradation of cytosolic Salmonella. Dikic demonstrated that Ser 473 and Ser 403 in the OPTN and p62ubiquitinbinding domains (UBAN and UBA), respectively, are also phosphoryl ated by TBK1, and that these modifica tions are crucial for Salmonella autophagy. Interestingly, Nobuyuki Nukina (RIKEN Brain Science Institute, Japan) and col leagues have discovered that casein kinase 2 (CK2) phosphorylates p62 Ser 403, increasing the affinity between UBA and Lys 63linked polyubiquitin chains, which then facilitates the targeting of polyubiq uitinated substrates for autophagic clear ance. Clearly, diverse signalling pathways regulate their downstream kinases to acti vate selective autophagy through both ubiquitin and LC3binding. Looking at the upstream events, Ramnik Xavier (Harvard Medical School, USA) showed that leucinerich repeat and sterile alpha motif containing 1 (LRSAM1), a previ ously identified interacting partner for the Atg8 family member gammaaminobutyric acid receptor associated proteinlike 2 (GABARAPL2), is an E3 ubiquitin ligase required for Salmonella autophagy. Further investigations are needed to address the issue of how LRSAM1 is targeted to the rup tured bacteriacontaining membrane struc tures and whether it mediates ubiquitination of the specific substrate(s). Paolo Manzanillo from Jeffery Cox's laboratory (U. California San Francisco, USA) provided surprising data suggesting that parkindeficient mice and flies are susceptible to bacterial infec tions, and that parkin marks cytosolic bac teria with Lys 63linked ubiquitin chains. It seems plausible that multiple protein kinases and E3 ubiquitin ligases cooperate efficiently to recognize the invading patho gens and target them to xenophagy through multiple autophagy receptors.
In normal cells, autophagy prevents tumorigenesis through selective cleanup of damaged organelles and specific proteins such as p62. Furthermore, cells with defec tive autophagy undergo necrotic cell death followed by inflammation, which enhances the incidence of tumorigenesis. However, it is uncertain whether autophagic activ ity is truly attenuated during tumori genesis in humans, and the molecular mechanisms also remain unclear. In 1999, beclin 1 was identified as a tumour sup pressor gene, suggesting for the first time a tumour suppressive role for autophagy [6] . Although the released beclin 1 induces autophagy, the free Bim might promote apoptosis. These presentations indicate that beclin 1 localization through phosphoryla tion by Akt or JNK controls autophagy, the dysregulation of which might be involved in tumorigenesis in humans.
Zhenyu Yue (Mount Sinai School of Medicine, USA) used beclin 1 conditional knockout mice to show that beclin 1 might be involved in multiple membrane transport pathways. However, it remains to be clarified whether impaired autophagy contributes solely to neoplasia in humans.
On the other hand, autophagy provides tumour cells-which require enormous quantities of nutrients-with a supply of amino acids, fatty acids and glucose, and has therefore been considered necessary for the efficient growth of malignant tumours. As such, autophagy satisfies the metabolic demands of tumours and enables their resist ance to the microenvironment once they become constantly proliferative, implying that autophagy is a doubleedged sword when it comes to cancer [7] . Cancer cells, particularly those with Ras mutations such as pancreatic cancer, rely heavily on autophagy to the extent of 'addiction'. Although the pre cise molecular mechanism remains unclear, the blockade of autophagy is sufficient to inhibit the proliferation of pancreatic cancer cells. Further, loss of autophagy in pancreatic cancer cells is accompanied by impaired oxidative phosphorylation, probably due to the decreased supply of intermediates from the tricarb oxylic acid cycle. Hence, it is plausible that cancer cells are 'addicted' to autophagy, as it is crucial to both the quality control of organelles, such as mito chondria and peroxisomes, and the supply of amino acids to support the survival and proliferation of cancer cells under metabolic stress conditions. Eileen White (The Cancer Institute of New Jersey at Rutgers U., USA) provided in vivo evidence of an essential role for autophagy in the malignant progression of oncogenic KRasinduced lung cancer. White's group has developed a genetically engineered mouse model for nonsmallcell lung cancer driven by oncogenic Kras with and without tumourspecific Atg7knockout. White revealed that KRasdriven tumori genesis was suppressed by loss of autophagy. Interestingly, the ablation of autophagy in lung tumour cells harbouring activated KRas resulted in more benign tumours. This obser vation is in good agreement with reports that spontaneous benign tumorigenesis is observed in the livers of mice with systemic mosaic deletion of Atg5, or with Atg7 dis rupted specifically in hepatocytes. By con trast, Kevin M. Ryan (The Beatson Institute for Cancer Research, UK) and colleagues demonstrated that loss of Atg7 in pancreatic ductal adenocarcinoma affects metabolic reprogramming, which affects tumour devel opment. Thus, autophagy might have differ ent roles in tumour development depending on cellular context, cancer stage and genetic background.
In conclusion, the past decade has seen the elucidation of diverse aspects of the autophagic process through the dissec tion of core Atg products. This symposium marked a new phase in which old players and newcomers in the autophagy family are discovered to connect to diverse pathways and functions. Fifty years after the coin ing of the phrase 'autophagy' by Christian de Duve, we have come to understand the necessity and importance of comprehen sive studies in the next step of autophagy targeted therapy for neurodegeneration, infectious diseases and cancer.
